As mentioned, Pfizer's major blockbusters have been on the decline, and that brings it to a major turning point. The company must renew its portfolio with a number of strong products that will drive ...

Among consumer staple stocks, many of which are also blue chip stocks, three stand out as strong buys in today's market: ...

The social media platform's underlying business is surging, and the stock's recent sell-off might be giving investors an ...

Shares of Lucid have fallen 98% from their peak, which some may see as an opportunity, even though it also highlights material risk.

Both Alphabet and Palantir are riding a massive wave of artificial intelligence demand, but a closer look at the two reveals ...

Defense spending is on the rise around the world, and these two companies are set for some serious growth because of it.

Tesla sells cars -- and the auto industry is notoriously cyclical. But Tesla's structure and long-term strategy may give it ...

Oil pushing toward $100 can make energy dividends look irresistible, but the best picks are the ones that don't need $100 oil ...

The geopolitical conflict in the Middle East has oil prices back in the headlines. Energy markets are in a state of flux, ...

Surprisingly, none of these incidents caused the stock price to drop, at least so far, showing investors that Amazon takes threats to its business seriously and does what it needs ...

Nebius and Meta Platforms are teaming up. Nebius is helping the social media colossus secure critical computing capacity.